Call highlights
XBP Global reported Q1 2026 revenue of $197.1 million, down 14.2% year-over-year on a pro forma basis, while closed total TCV of $108.1 million rose 68.8% year-over-year and the board approved a formal exploration of strategic alternatives.
“our board of directors has authorized a formal process to explore strategic alternatives. Given the deep discount at which our stock trades relative to our intrinsic value and the desire to be more focused on core growth engines, we believe this is the right step to unlock value for all stakeholders. The company will consider a variety of potential options, which could also include divestitures.”
- Gross margin expanded 70 bps year-over-year on a pro forma basis to 22.9%, marking a third consecutive quarter of margin expansion.
- Closed $108.1 million of total TCV, a 68.8% increase year-over-year and 45.1% above the trailing four-quarter average.
- Pipeline grew 17% year-over-year and 10% quarter-over-quarter, with mid- to late-stage TCV up nearly 45% year-over-year.
- Closed $27.3 million of new ACV from over 460 transactions in Q1, with bookings diversified across industries.
- Management expects AI pipelines achieving 40%-60% first-pass auto-resolution to reach 85% or more over time, driving accelerated margin expansion and a positive EBITDA inflection in the second half.
- Expects approximately $55 to $60 million in annualized operational efficiencies from company-wide automation, with a significant portion of underlying actions implemented in the first half of 2026.
- Revenue declined 14.2% year-over-year on a pro forma basis to $197.1 million, reflecting the tail end of legacy restructuring.
- Normalized EBITDA decreased 39.9% year-over-year on a pro forma basis to $15.6 million.
- Reported a net loss of $26.8 million.
- New ACV declined 3.7% year-over-year, though it was 4.4% above the trailing four-quarter average.
- Applied Workflow Automation revenue fell 12.6% year-over-year and Technology revenue fell 26.4% year-over-year.
- Expects an approximate 20% reduction in global headcount by the end of 2026 compared to year-end 2025, subject to timing and execution of automation initiatives.
Guidance
from the 8-K filed May 14, 2026| Metric | Period | Guided | Basis |
|---|---|---|---|
| Annualized operational efficiencies | resulting from Company-wide automation efforts | $55M – $60M | — |
| Global headcount reduction Initiated | by the end of 2026 | 20% | — |
Good day, and welcome to the XBP Global First Quarter 2026 Financial Results. At this time, all participants are in a listen-only mode. After the speaker's presentation, there'll be a question-and-answer session. To ask a question, you will need to press star 11 on your touchstone telephone. Please note this call is being recorded. I'm going to turn the call over to David Shamus, Head of Investor Relations. Please go ahead.
Thank you, and good afternoon, everyone. Welcome to XBP Global's First Quarter 2026 Earnings Call. Joining me are CEO, Andrey Jonovich, CFO, Dan Abramovich, and our Chief Revenue Officer, Mike Schufeld. Before we begin, please note that today's remarks may contain forward-looking statements, including statements regarding our future performance, outlook, and strategy. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those described. For detailed discussion of these risks and uncertainties, please refer to our filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and our proxy statement and other filings with the SEC, copies of which are available on our Investor Relations website at investors.xbpglobal.com. We will also reference certain pro forma and non-GAAP financial measures. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measures included in our earnings release and the appendix to our investor presentation which are available on our investor relations website with that i'll turn the call over to entre good afternoon everyone
and thank you for joining us please allow me to sum up the journey that we're on at the prior call in late march covering q4 and full year 2025 i talked about the integration of the two platforms which came together in mid-2025, the voluntary disruption of ourselves to become an AI-led company, and the investments we're making in growth, primarily focusing on the expanded sales team. While it's only been about six weeks since that earnings call, we're further along on I would like to spend a little bit of time updating you with a greater focus on the how we intend to become an AI-led company. We're converting the workflows that defined our business process as a solution business into AI pipelines. And we're doing it on our own timeline rather than the markets. This is a deliberate shift in how mission-critical workflows are delivered. Let me give you some context before we walk through the investor deck. Historically, the business process as a solution, or BPaaS model, existed to manage the exceptions and complexities that legacy platforms could not address. This is where our domain expertise resides, in the rules, workarounds, and institutional knowledge required to deliver outcomes, especially for heavily regulated industries like health care, banking, financial services, and the public sector. Our differentiation is regulatory-grade precision delivered through a unified execution layer, a combination which we believe resonates well with the ongoing needs of our clients. Our regulatory depth means we're able to navigate the rigorous security and oversight requirements of highly complex and regulated clients where pure-play AI lacks the necessary accountability to operate. We're operationalizing our agentic AI at scale. This means that we are providing the last mile of oversight using human-in-the-loop processes and bridging data gaps within unstructured and physical data sets. and we then seamlessly integrate everything into our modular cloud-native execution layer. Together, these capabilities create a formidable, competitive moat that is difficult for competitors to replicate. I'd like us to turn to the investor deck and slide five. We're now transitioning these proven workflows into AI pipelines. A cornerstone of this shift is our patented Komodo rule engine, which has long used binary Boolean logic to automate workflows. We have begun migrating these rules into inference-based models powered by LLMs. Our process is unique. Our subject matter experts, or SMEs, create logic diagrams and standard operating procedures, SOPs, for edge cases. To remain cost-effective and highly precise, we distill these into smaller, domain-specific models tuned for each area of expertise. This allows us to deploy secure private models powered by proprietary SME knowledge, unified software platform, and intelligent engines. This approach ensures we uphold the highest ethical AI standards and complete data privacy for our clients. A key element of our strategy is value over volume. Our goal is broad adoption of these AI pipelines to capture a larger wallet share of our trusted clients. Today, at the inception of a deployment, we're achieving approximately 40% to 60% first-pass auto-resolution rate. This continuously improves to about 85% or more over time. The remaining 15% becomes a new version of BPaaS, a highly focused human-in-the-loop function where our SMEs resolve the final exceptions and continuously train the AI to reduce that 15% even further. Let me help you contextualize this better. Traditional industry automation tools typically have auto-resolution rates which are somewhere between 20% to 35%. This rises to a higher percentage once workloads are matured over multi-year horizons. The workloads we're migrating start at a higher auto-resolution percentage and build our way higher up than the industry. In some cases, the remaining 15% can be reduced to a fraction. We're already seeing this model work at scale in our healthcare business, which is effectively a $200 million-plus business for us. This is our most advanced sector for AI deployment, and we're also making significant progress forward in the public sector using the same approach. Slide six walks through an example of how our healthcare AI pipeline operates. What was once a legacy process burdened by management overhead, training time, quality control, rework, and various other hidden operational costs and burdens can be transitioned to an agentic workflow, taking paper, unresolved claims, and converting them into a high-quality digital payload that can be processed into paid claims, thereby improving efficiencies in the healthcare industry. But automating the routine work, this new workflow significantly reduces processing time, lowers manual effort, cuts down handoffs, improves consistency, and helps providers get paid faster. While there is still a human in the loop element, this is reserved for cases that truly require judgment, expertise, or simply put, human accountability. It's also important to note that we're just getting started with this journey. While we've seen margin expansion in the last few quarters, we expect this expansion to accelerate, and for this to drive a positive inflection in our EBITDA trajectory in the second half of the year. Finally, as we announced earlier today, our board of directors has authorized a formal process to explore strategic alternatives. Given the deep discount at which our stock trades relative to our intrinsic value and the desire to be more focused on core growth engines, we believe this is the right step to unlock value for all stakeholders. The company will consider a variety of potential options, which could also include divestitures. We've been investing in talent that we believe will help us along this journey. We recently announced the hiring of a CHRO, Aquelia Colaco, and we've decided to invite a rather recent joiner, Mike Schufelt, who is our Chief Revenue Officer, to this call. I will hand over to Mike, who will walk you through our sales strategy and pipeline.
Thanks, Andre. Let's turn to slide seven, where we'll walk through our revenue and pipeline momentum. With respect to our sales performance, we are currently seeing a tail of two timelines. While our top-line revenue for the quarter reflects the tail end of our legacy restructuring, our forward-looking indicators have never been stronger. Short-term revenue remains measured as we transition away from manual, volume-based processing toward our agentic AI-powered platforms. We are intentionally building a pipeline that is more durable and higher margin, even if the revenue recognition cycles are longer than the legacy business we've replaced. Turning to our pipeline. In the past two months, we have seen a substantial acceleration in our pipeline, with 17% growth from a year ago, 10% growth from last quarter. Specifically, our total contract value, or TCV, in the mid- to late-stage funnel has expanded by nearly 45% compared to a year ago. What's even more encouraging is the velocity. These aren't just leads. These are enterprise-wide transformation programs where XBP is being integrated as the focal point for workflow. We are seeing customers move from AI curiosity to AI production, and our acceleration of specific agentic AI technology ensures that we can scale as these contracts come online. If there's one area that truly defines our current strength, it is the public sector. In February, Everest Group, a leading global research and advisory firm, released a report that recognized our AI-driven document processing capabilities as foundational to public sector automation, underscoring the importance of governance, auditability, and regulatory alignment. Following the validation from Everest, we've seen an influx of high demand for highly secure on-premise automation. Government entities are no longer looking for simple scanning. They need agentic AI that can handle sensitive healthcare and citizen data with human-in-the-loop oversight. We see tremendous momentum in the U.S. public sector, and our recent win in a major French health insurance institution is another prime example. It started as a 1 million euro pilot and is already showing signs of expanding into a multi-year, multi-departmental program. Across Europe and the Americas, the public sector is becoming the backbone of our midterm growth. To sum up, our short-term numbers were a snapshot of what we were, but our pipeline is a roadmap to where we are going. We are choosing to build a high-quality, repeatable growth engine. The demand for hyperautomation is at a generational peak, and XBP is now positioned to capture the largest, most complex deals in our history. I look forward to updating you as these pipeline wins convert into recognized revenue throughout the second half of the year. With that, I will now turn the call over to Dan Avromovic, our CFO.
Thank you, Mike, and good afternoon, everyone. I will now walk you through our financial and operating results for the quarter. Similar to prior quarters, my comments will primarily focus on pro forma results to reflect the combined operations of BPA and XBP Europe on an apples-to-apples basis as it relates to any comparisons versus prior periods. Starting on slide 9, for the first quarter of 2026, we had total revenue of $197.1 million, a decline of 14.2 percent year-over-year, and our gross margin increased by 70 basis points year-over-year to 22.9 percent, driven by margin expansion in our applied workflow automation segment. Our normalized EBITDA was $15.6 million, a decline of 39.9% year-over-year. As I have discussed previously, these revenue and EBITDA declines can largely be attributed to the expected restructuring-related exits. As a reminder, pipeline creation in the Americas business, formerly BPA, was significantly impacted over the course of the company's bankruptcy process which lasted several quarters. Since onboarding Mike and investing in an expanded sales force over the last two quarters, we're seeing positive momentum on the sales funnel. Like Mike alluded to in his prepared remarks, we have seen a substantial increase in our pipeline in the last few months alone, and this helped drive 68.8% increase in our total TCV bookings in a quarter versus a year ago. Our total TCV bookings in this quarter were also 45% above the previous four quarter average. Our new ACV bookings were down 3.7% from a year ago, but up 4.4% over the last four quarter average. Moving to slide 10, which reviews our segment breakdown. In the first quarter, the applied workflow automation segment had a revenue decline of 12.6% year over year on a pro forma basis. Sequentially, revenue in this segment was down 3.7%. Gross margins, however, increased by 260 basis points year-over-year and 190 basis points sequentially to 19.9%. This represents our highest gross margin for this segment to date. Our technology revenue declined by 26.4% year-over-year and 14% sequentially. As a reminder, the technology segment includes the sale of software licenses, along with hardware solutions and maintenance, and results in this segment tend to be lumpier. The reason for the decrease in technology revenue and margin this quarter was due to lower one-time projects, delays in a handful of larger deals, and expected customer exits. Going forward, we would expect a gross margin of approximately 55 to 60 percent for this segment in line with previous periods. Turning to slide 10, while our revenue declined this quarter, which again was primarily driven by revenue attrition as a result of BPAs restructuring, we continue to see an uptick in gross margin with three straight quarters of margin expansion in a row. As we look forward throughout the year, there are a few things I'd like to point out. First, given the growth in our pipeline and recent TCV wins, we have increased confidence that our quarterly revenue will be stable in the near term and that we will experience revenue growth in the second half of 2026. Secondly, we expect gross margin increases to accelerate as our sales pipeline converts in the second half of the year with a greater focus on agentic workflows and higher use of automation. With respect to the normalized EBITDA decline in the quarter, this was primarily driven by lower volumes, a handful of expected customer exits, and further investments in people which drove higher SG&A in the quarter. In addition, as we highlight on slide 12, we expect an approximate 20% reduction in our global workforce by the end of the year compared to the end of 2025 as a result of AI-driven productivity and efficiency. Combined with over 80 non-payroll initiatives, we're expecting approximately $55 to $60 million in annual operational efficiencies with nearly half of these underlying actions implemented to date but not yet reflected in our financials. Combined with stabilizing revenue and increasing gross margin, we believe that we've reached an inflection point and expect to see a meaningful step up in our performance throughout the year as a result of these actions, starting with an increase in normalized EBITDA next quarter.
With that, I'll turn it back to Andre. Thanks, Dan. We've seen a steady decrease in our headcount over the last several quarters as you can see on slide 13 given the workforce rationalization that automation is generating we expect further significant change to the way we operate creating a leaner more nimble and more effective enterprise with respect to the revenue per employee metric which i've talked about in the past we currently stack near the top of our publicly traded peer group at approximately $82,000. Based on our projected year and headcount, we expect our revenue primarily on a pro forma basis to lead these peers by a wide margin, putting us somewhere around $100,000 per employee versus the peer average of approximately $60,000. We expect to continue to separate ourselves from the legacy business process automation pack with a focus on lean, efficient, high-margin growth with ever-increasing use of automation. Skipping ahead to slide 16, as Mike mentioned earlier, we've seen positive momentum in our TCV signings and the overall pipeline growth. We're still in the early stages, so it would not be prudent of me to state what exactly we expect the revenue growth inflection point. On the right side, we show our new ACV signings by industry, and the key takeaway here is that our bookings are diversified and not overly focused in any one industry. In the first quarter, we closed 27.3 million of new ACV from over 460 separate transactions. The public sector was an area of success for us this quarter. And like Mike mentioned in his comments, we think the public sector is a growing area of opportunity for us as governments around the world embrace AI in order to create higher efficiencies. I'd now like to thank our dedicated team for their continued efforts. And with that, I'll turn it over to the operator to open up for questions and answers. Operator.
Thank you. As a reminder, to ask a question, please press star 1-1. And our first question comes from Anand Balaji with Cancer Fitzgerald. Your line is open.
Hey, guys. Congrats on the quarter and all the progress, and thanks for taking our questions. I just wanted to start by touching on the TCV momentum. You know, you closed with over $100 million in TCV in the quarter, up by a lot. I was wondering if you could talk to us about what drove the step up this quarter, whether it's momentum coming from more renewals, win backs, or new enterprise mandates, and maybe how do you expect that TCV momentum to trend over the next few quarters as your sales pipeline, especially in North America, is back on?
Hi, this is Mike. Thanks for the question. I do think it's a great mix of new bookings and renewal. And we expect to see more of that momentum that we talked about, not just in the public sector, but in other aspects as well. And so we expect a healthy mix of those two things.
Appreciate the color. And I wanted to touch on AI as well as a follow-up. You guys highlighted a transition from, you know, legacy rules-based workflows into agentic AI pipelines, 40% to 60% initial auto resolution today. I was wondering maybe can you discuss where you're seeing the most tangible progress from AI automation so far? And can you talk about what gives your AI applications an edge versus your clients doing it themselves in-house or potentially what competitors are doing? Thank you.
Sure. This is Andre. Thanks for the question, And. I mean, there's sort of a multi-pronged answer to this. We have, as we have said many times, you know, decades of experience, a lot of deep domain knowledge. We also have built rules along the way that have expanded over time to give us a certain baseline automation level. We're supplementing that with an entirely new stack that's able to achieve higher automation rates up front and then work its way higher up thereafter. I don't know. It's not always possible to say we're definitely better than so-and-so. What I can tell you is that when we interact with clients, we can see that the client's reactions are suggesting that this is highly valuable to them. and I think these discussions that we're having are giving us a lot of encouragement so I think to some extent competitors will do what they do and even clients will attempt to do some of these things themselves but I can also tell you that we've won clients who have attempted to do this themselves and haven't been successful so when they reached out to us And when we've socialized with them, our approach, those have yielded beneficial outcomes for us and the clients.
And maybe if I could sneak one last one in. You guys announced a formal review of strategic alternatives. Maybe can you help frame for us what the board considers core versus non-core within XBP's current portfolio? And how does this process help simplify the business while preserving that AI-first workflow automation strategy?
Thanks, Anand. Again, it's a great question, very pertinent. You know, we're a reasonably large, substantial enterprise with a lot of different businesses within it. These carry a lot of intrinsic value on their own, and we don't think that our company as a whole is getting the right kind of valuation from the public markets. We are interacting with advisors. We expect to select one advisor in the near term, and the board will take cue and advice from the advisors in deciding how to proceed. So I think this remains very much an open-ended and open-minded process, and we haven't made any conclusions yet pending the advice from advisors.
Thanks again for all the comments.
Thank you.
Appreciate it. Thank you. This concludes the question and answer session. Thank you for your participation, and you may now disconnect. Everyone, enjoy the rest of your day.